Intelligent Bio Solutions (INBS) Liabilities and Shareholders Equity (2021 - 2024)
Historic Liabilities and Shareholders Equity for Intelligent Bio Solutions (INBS) over the last 4 years, with Q1 2024 value amounting to $17.0 million.
- Intelligent Bio Solutions' Liabilities and Shareholders Equity rose 5970.97% to $17.0 million in Q1 2024 from the same period last year, while for Mar 2024 it was $44.9 million, marking a year-over-year increase of 938.0%. This contributed to the annual value of $10.4 million for FY2023, which is 1617.17% down from last year.
- Intelligent Bio Solutions' Liabilities and Shareholders Equity amounted to $17.0 million in Q1 2024, which was up 5970.97% from $8.8 million recorded in Q4 2023.
- Over the past 5 years, Intelligent Bio Solutions' Liabilities and Shareholders Equity peaked at $21.9 million during Q2 2021, and registered a low of $8.7 million during Q3 2023.
- For the 4-year period, Intelligent Bio Solutions' Liabilities and Shareholders Equity averaged around $14.4 million, with its median value being $14.4 million (2022).
- Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first plummeted by 5109.14% in 2023, then skyrocketed by 5970.97% in 2024.
- Over the past 4 years, Intelligent Bio Solutions' Liabilities and Shareholders Equity (Quarter) stood at $19.1 million in 2021, then decreased by 5.55% to $18.0 million in 2022, then tumbled by 51.09% to $8.8 million in 2023, then surged by 93.03% to $17.0 million in 2024.
- Its last three reported values are $17.0 million in Q1 2024, $8.8 million for Q4 2023, and $8.7 million during Q3 2023.